Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:AKAN News 5 December 2025 - 12 December 2025

Akanda Corp (AKAN) Stock News Today: Why Shares Are Jumping on Dec. 12, 2025 — Latest Forecasts, Filings, and What to Watch

Akanda Corp (AKAN) Stock News Today: Why Shares Are Jumping on Dec. 12, 2025 — Latest Forecasts, Filings, and What to Watch

Updated: December 12, 2025 Akanda Corp (NASDAQ: AKAN ) is back on traders’ radars Friday after a sharp premarket move and unusually heavy volume for a micro-cap stock. Early on Dec. 12, 2025 , AKAN showed up on multiple “top movers” lists, with premarket quotes and percentage gains shifting quickly as trading activity accelerated.Stock Analysis+ 2Benzinga+ 2 What makes AKAN especially notable right now is the mix of catalysts and structure : a very small reported share base around late November, a “dual-track” story tied to telecom infrastructure in Mexico plus a cannabis licensing pathway in Canada , and recent
12 December 2025
·
Akanda Corp (AKAN) Stock Soars After Shareholder Vote: Reverse Merger, Mexico Towers and 2025–2030 Forecasts

Akanda Corp (AKAN) Stock Soars After Shareholder Vote: Reverse Merger, Mexico Towers and 2025–2030 Forecasts

Published: December 5, 2025 Akanda Corp’s Nasdaq-listed shares (ticker: AKAN) are back in the spotlight after a dramatic late‑week move. On Thursday evening, the micro‑cap stock surged about 45% in after‑hours trading to roughly $1.37, after the company disclosed that shareholders had approved sweeping capital‑structure changes linked to its reverse merger with First Towers & Fiber Corp and a package of convertible debt. Benzinga+2Stock Titan+2 The spike caps a volatile stretch in 2025 during which Akanda has tried to reinvent itself from a tiny, loss‑making medical cannabis company into a hybrid telecom‑infrastructure and cannabis play with operations in Mexico and
5 December 2025
···

Stock Market Today

Philip Morris stock price: PM steadies near $183 after upbeat 2026 forecast puts Zyn battle back in view

Philip Morris stock price: PM steadies near $183 after upbeat 2026 forecast puts Zyn battle back in view

7 February 2026
New York, Feb 7, 2026, 15:18 EST — Market closed. Philip Morris International shares last stood at $182.81, up 0.45% from the prior session, after the company laid out a higher 2026 profit outlook tied to its nicotine pouch business. (Reuters) That matters now because the stock has become a referendum on whether smoke-free products can keep carrying earnings while the category gets crowded. Zyn is the big swing factor, and traders are watching for any sign that volume gains are coming at the cost of pricing power. With U.S. markets shut for the weekend, the next test comes at
AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Go toTop